Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation | Zendy

P. M. Grant | Zendy; Douglas Kitch | Zendy; Grace A. McComsey | Zendy; Michael P. Dubé | Zendy; R Haubrich | Zendy; Jeannie S. Huang | Zendy; Sharon A. Riddler | Zendy; Pablo Tebas | Zendy; Andrew Zolopa | Zendy; Ann C. Collier | Zendy; Todd T. Brown | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation

Author(s) -

P. M. Grant,

Douglas Kitch,

Grace A. McComsey,

Michael P. Dubé,

R Haubrich,

Jeannie S. Huang,

Sharon A. Riddler,

Pablo Tebas,

Andrew Zolopa,

Ann C. Collier,

Todd T. Brown

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit538

Subject(s) - medicine , bone mineral , body mass index , regimen , linear regression , bone density , viral load , immunology , gastroenterology , endocrinology , human immunodeficiency virus (hiv) , osteoporosis , machine learning , computer science

Bone mineral density (BMD) decreases 2%-6% in the 2 years after antiretroviral therapy (ART) initiation. Pre-ART immune deficiency and early immune recovery may contribute to this loss.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research